3D NEONET
3D NEONET is a 18-partner H2020 Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) programme (H2020-MSCA-RISE-2016) funded under “Stimulating innovation by means of cross-fertilisation of knowledge” coordinated by University College Dublin in Ireland.
The overall goal of 3D-NEONET is the improvement of available treatments for cancer and ocular disease by enhancing drug discovery-development and delivery to targeted tissues, through advanced international co-operation between academic and non-academic partners.
The interdisciplinary expertise provided by 18 partners in 7 countries encompasses among others: drug screens, ADME, toxicology, preclinical models, nanotechnology, biomaterials and clinical trials.
Read more here.
